Capturing the Complexity of the Tumor Microenvironment, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will discuss why gaining insights into the TME and immune contexture of tumors is crucial for deciphering immunotherapies mechanisms of action. They will explain how biomarker evaluation can be defined and set up and which type of innovative technologies can support this evaluation and provide meaningful information to biopharma companies.

Xtalks Life Science Webinars

This unique solution can assist biopharma companies to get meaningful insights from their samples used in clinical trials and gain knowledge in drug mechanism of action and its impact on the immune contexture of the tumor.

Immunotherapeutic approaches have revolutionized the treatment of multiple cancers and a large diversity of immunomodulation technologies compete now to reach market authorization.

It is accepted that the characteristics of each patient’s tumor microenvironment (TME) before, during and after a treatment have a major influence on therapy response. The challenge for immunotherapies developers is then to map the key biomarkers of this very complex and diverse TME, to link them to the mechanism of action of the investigated drug and leverage this information with the objective of rationalizing and accelerating the pace of clinical programs from early phases to registration.

The TMExploreTM is a unique tissue-based approach, developed by HalioDx, combining different technologies and an in-house immuno-oncology expertise perfectly adapted to the comprehensive characterization of the tumor microenvironment. From one to hundreds of biomarkers, this customizable solution allows to identify precise cell populations, observe gene expression profiling and focus on biomarkers spatial analysis via multiplex IHC technologies. All those parameters can be combined into an Immunogram multimodal analysis, providing a 360 degree view of the tumor microenvironment.

This unique solution can assist biopharma companies to get meaningful insights from their samples used in clinical trials and gain knowledge in drug mechanism of action and its impact on the immune contexture of the tumor.

Join Jérôme Galon, PhD, Director, Inserm, Cordeliers Research Center, Paris, France and Jacques Fieschi, PhD, VP R&D HalioDx in a live webinar on Monday, May 4, 2020 at 11am EDT (4pm BST/UK).

For more information or to register for this event, visit Capturing the Complexity of the Tumor Microenvironment.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sydney Perelmutter
Xtalks
+1 (416) 977-6555 x 352
Email >
Visit website